Literature DB >> 10995417

Apoptosis in the skeletal muscle of patients with heart failure: investigation of clinical and biochemical changes.

G Vescovo1, M Volterrani, R Zennaro, M Sandri, C Ceconi, R Lorusso, R Ferrari, G B Ambrosio, L Dalla Libera.   

Abstract

OBJECTIVE: To investigate the contribution of apoptosis in the development of the skeletal myopathy in chronic heart failure.
DESIGN: The electrophoretic pattern of myosin heavy chains (MHC), fibre cross sectional area, number of in situ nick end labelling (TUNEL) positive apoptotic myocyte nuclei, and the tissue levels of caspase-3, Bcl-2, and ubiquitin were determined in biopsies taken from the vastus lateralis muscle. The study involved nine patients with severe chronic heart failure caused by ischaemic heart disease and hibernating myocardium and five controls.
RESULTS: In chronic heart failure patients the vastus lateralis showed a significant increase of MHC(2a) and MHC(2b) and a greater degree of fibre atrophy, as demonstrated by the decreased cross sectional area. There was also an increased number of TUNEL positive apoptotic myocyte nuclei. Tissue concentrations of Bcl-2 were decreased, while those of caspase-3 and ubiquitin were increased. Peak oxygen consumption (VO(2)) was negatively correlated with the number of TUNEL positive nuclei and the fibre cross sectional area. There was a correlation between the number of apoptotic nuclei and the fibre cross sectional area, but no correlation between myosin heavy chains and number of apoptotic nuclei.
CONCLUSIONS: Myocyte apoptosis occurs in the skeletal muscle of patients with chronic heart failure, and its magnitude is associated with the severity of exercise capacity limitation and the degree of muscle atrophy. Muscle atrophy contributes to the limitation of exercise capacity, together with the increased synthesis of fast, more fatiguable myosin heavy chains.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10995417      PMCID: PMC1729437          DOI: 10.1136/heart.84.4.431

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  36 in total

1.  Skeletal muscle metabolism during exercise under ischemic conditions in congestive heart failure. Evidence for abnormalities unrelated to blood flow.

Authors:  B M Massie; M Conway; B Rajagopalan; R Yonge; S Frostick; J Ledingham; P Sleight; G Radda
Journal:  Circulation       Date:  1988-08       Impact factor: 29.690

2.  Detection of abnormal calf muscle metabolism in patients with heart failure using phosphorus-31 nuclear magnetic resonance.

Authors:  D M Mancini; N Ferraro; M Tuchler; B Chance; J R Wilson
Journal:  Am J Cardiol       Date:  1988-12-01       Impact factor: 2.778

3.  Skeletal muscle metabolism in heart failure: a 31P nuclear magnetic resonance spectroscopy study of leg muscle.

Authors:  L Arnolda; M Conway; M Dolecki; H Sharif; B Rajagopalan; J G Ledingham; P Sleight; G K Radda
Journal:  Clin Sci (Lond)       Date:  1990-12       Impact factor: 6.124

4.  Specific changes in skeletal muscle myosin heavy chain composition in cardiac failure: differences compared with disuse atrophy as assessed on microbiopsies by high resolution electrophoresis.

Authors:  G Vescovo; F Serafini; L Facchin; P Tenderini; U Carraro; L Dalla Libera; C Catani; G B Ambrosio
Journal:  Heart       Date:  1996-10       Impact factor: 5.994

5.  Muscle mass as a factor limiting physical work.

Authors:  R J Shephard; E Bouhlel; H Vandewalle; H Monod
Journal:  J Appl Physiol (1985)       Date:  1988-04

6.  Skeletal muscle biochemistry and histology in ambulatory patients with long-term heart failure.

Authors:  M J Sullivan; H J Green; F R Cobb
Journal:  Circulation       Date:  1990-02       Impact factor: 29.690

7.  Role of muscle loss in the age-associated reduction in VO2 max.

Authors:  J L Fleg; E G Lakatta
Journal:  J Appl Physiol (1985)       Date:  1988-09

8.  Exercise ventilation and pulmonary artery wedge pressure in chronic stable congestive heart failure.

Authors:  L I Fink; J R Wilson; N Ferraro
Journal:  Am J Cardiol       Date:  1986-02-01       Impact factor: 2.778

9.  Abnormalities of skeletal muscle in patients with chronic heart failure.

Authors:  D P Lipkin; D A Jones; J M Round; P A Poole-Wilson
Journal:  Int J Cardiol       Date:  1988-02       Impact factor: 4.164

10.  Evaluation of energy metabolism in skeletal muscle of patients with heart failure with gated phosphorus-31 nuclear magnetic resonance.

Authors:  J R Wilson; L Fink; J Maris; N Ferraro; J Power-Vanwart; S Eleff; B Chance
Journal:  Circulation       Date:  1985-01       Impact factor: 29.690

View more
  39 in total

1.  Activation of caspase-3 is an initial step triggering accelerated muscle proteolysis in catabolic conditions.

Authors:  Jie Du; Xiaonan Wang; Christiane Miereles; James L Bailey; Richard Debigare; Bin Zheng; S Russ Price; William E Mitch
Journal:  J Clin Invest       Date:  2004-01       Impact factor: 14.808

2.  Contributions of the ubiquitin-proteasome pathway and apoptosis to human skeletal muscle wasting with age.

Authors:  Samantha A Whitman; Michael J Wacker; Scott R Richmond; Michael P Godard
Journal:  Pflugers Arch       Date:  2005-06-11       Impact factor: 3.657

3.  Heart failure alters matrix metalloproteinase gene expression and activity in rat skeletal muscle.

Authors:  Robson Francisco Carvalho; Rafael Dariolli; Luis Antonio Justulin Junior; Mário Mateus Sugizaki; Marina Politi Okoshi; Antonio Carlos Cicogna; Sérgio Luis Felisbino; Maeli Dal Pai-Silva
Journal:  Int J Exp Pathol       Date:  2006-12       Impact factor: 1.925

Review 4.  Exercise intolerance.

Authors:  Dalane W Kitzman; Leanne Groban
Journal:  Heart Fail Clin       Date:  2008-01       Impact factor: 3.179

5.  [Exercise training in heart failure].

Authors:  F Edelmann; B Pieske
Journal:  Herz       Date:  2013-09       Impact factor: 1.443

Review 6.  Proteolysis in illness-associated skeletal muscle atrophy: from pathways to networks.

Authors:  Simon S Wing; Stewart H Lecker; R Thomas Jagoe
Journal:  Crit Rev Clin Lab Sci       Date:  2011-06-24       Impact factor: 6.250

7.  Reduced handgrip strength as a marker of frailty predicts clinical outcomes in patients with heart failure undergoing ventricular assist device placement.

Authors:  Christine J Chung; Christina Wu; Meaghan Jones; Tomoko S Kato; Tien T Dam; Raymond C Givens; Danielle L Templeton; Mathew S Maurer; Yoshifumi Naka; Hiroo Takayama; Donna M Mancini; P Christian Schulze
Journal:  J Card Fail       Date:  2014-02-22       Impact factor: 5.712

Review 8.  Muscle wasting and cachexia in heart failure: mechanisms and therapies.

Authors:  Stephan von Haehling; Nicole Ebner; Marcelo R Dos Santos; Jochen Springer; Stefan D Anker
Journal:  Nat Rev Cardiol       Date:  2017-04-24       Impact factor: 32.419

9.  The Role of Congestion in Cardiorenal Syndrome Type 2: New Pathophysiological Insights into an Experimental Model of Heart Failure.

Authors:  Annalisa Angelini; Chiara Castellani; Grazia Maria Virzì; Marny Fedrigo; Gaetano Thiene; Marialuisa Valente; Claudio Ronco; Giorgio Vescovo
Journal:  Cardiorenal Med       Date:  2015-10-31       Impact factor: 2.041

Review 10.  Implications of chronic heart failure on peripheral vasculature and skeletal muscle before and after exercise training.

Authors:  Brian D Duscha; P Christian Schulze; Jennifer L Robbins; Daniel E Forman
Journal:  Heart Fail Rev       Date:  2008-02       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.